Retrospective multicenter clinical study of Conversion rate of hydromorphone in cancer patients

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1040220043

Enrollment

Registered

2022-07-14

Start date

2022-07-14

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inpatients who changed the route of hydromorphone from injectable to oral

Exclusion criteria

Exclusion criteria: (1)Patients treated with chemotherapy or radiotherapy in the 24 hours before and after rerouting (2)Patients who were using opioids other than hydromorphone (3)Patients with difficulty in pain assessment

Design outcomes

Primary

Measure	Time frame
The conversion ratio from intravenous hydromorphone to oral hydromorphone	—

Secondary

Measure	Time frame
Factors affecting conversion ratios	—

Contacts

Public ContactKazuyo Nakamura

Shizuoka General Hospital

kazuyo-nakamura@i.shizuoka-pho.jp+81-54-247-6111

Outcome results